COVID-19 more severe with certain rheumatic diseases: study
Patients on biologics, but not conventional DMARDs, are also at increased risk, researchers say
Certain rheumatoid conditions and therapies are associated with higher risk for COVID-19, researchers say.
A study from Spain shows patients with spondyloarthritis, polymyalgia rheumatica or giant cell arteritis, and those on biologics and targeted-synthetic therapies, are at higher risk for hospital-diagnosed COVID-19 infection compared with the general population.
